Application Note:  Assessment of Mesenchymal Stem Cell (MSC) Identity and Differentiation

Authors: Natasha Lewis, Jasmine Trigg, Daryl Cole, Nicola Bevan Last updated: February 2025

Overview

Application Note: High-Throughput Screening Cytometry Provides Comprehensive Assessment of Mesenchymal Stem Cell (MSC) Identity and Differentiation

Mesenchymal stem cells (MSCs) are multipotent adult stem cells that can be characterized by their ability to self-renew and their potential to differentiate into multiple cell types including osteoblasts, chondrocytes, and adipocytes.

MSCs role in tissue repair and in immune modulation, provides great interest, in researching mechanisms of cell signaling, differentiation, and tissue engineering. They also have a cell therapy role in a wide range of illnesses, including autoimmune disorders and musculoskeletal conditions.

The efficacy and safety of stem cell-based therapies requires insights into cell identity and behavior. Examination of the surface marker expression of MSCs can offer those insights. 

Examination of the changes in cell surface markers expression profiles over time, and in response to various cell culture conditions or stimuli, enables the rapid assessment of MSC differentiation.

iQue® High Throughput Screening (HTS) by Cytometry, offers an ideal solution in providing detailed analysis of surface marker expression on MSCs, with high efficiency, reliability and precision. HTS Cytometry facilitates comprehensive quality control measures of cell viability and health, and also consistency within and between batches. The iQue® ‘s multiparametric cytometry capabilities allow for the concurrent analysis of a large panel of markers, providing an efficient tool for complex regenerative medicine assessments.

 

  • Document type: Application Note
  • Page count: 8
  • Read time: 8 minutes

 

Complete the Form to Access the Application Note 

Key Takeaways

  • This application note highlights the ability of iQue® HTS Cytometry to detect shifts in marker expression, such as decreased MSC-positive markers alongside increased CD34 and CD45 during differentiation, and the rise in ALPL and FABP4 as indicators of osteoblastic and adipogenic maturation, respectively.
  • By providing rapid, multiparametric analysis, HTS Cytometry enhances workflow efficiency and data reliability, supporting the advancement of MSC applications in regenerative medicine.

Request a Quote, Demo, or More Information

What other areas are you interested in? (select all that apply)

Please Provide your Information to Download this Application Note

icon-shopping-cart
Ready to Buy?